Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by […]
Source
Drugs facing the most patent expirations this year Read Post »
Annual Drug Patent Expirations for AUSTEDO+XR Austedo Xr is a drug marketed by Teva and is included in one NDA. […]
Source
Annual Drug Patent Expirations for NUCYNTA+ER Nucynta Er is a drug marketed by Collegium Pharm Inc and is included in […]
Source
Annual Drug Patent Expirations for INVOKAMET Invokamet is a drug marketed by Janssen Pharms and is included in two NDAs. […]
Source
New patent expiration for Janssen Pharms drug INVOKAMET Read Post »
Annual Drug Patent Expirations for SOHONOS Sohonos is a drug marketed by Ipsen and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for INLYTA Inlyta is a drug marketed by Pf Prism Cv and is included in one […]
Source
Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and Teva and is included […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Annual Drug Patent Expirations for ALOXI Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs. […]
Source
New patent expiration for Helsinn Hlthcare drug ALOXI Read Post »
Annual Drug Patent Expirations for INVOKAMET+XR Invokamet Xr is a drug marketed by Janssen Pharms and is included in one […]
Source
New patent expiration for Janssen Pharms drug INVOKAMET XR Read Post »